Division of Cardiology, Heart Institute, Children's Hospital Colorado, University of Colorado Denver, Anschutz Medical Campus, Aurora, Colorado.
Linda Crnic Institute for Down Syndrome, University of Colorado Denver, Aurora, Colorado.
Am J Physiol Heart Circ Physiol. 2021 Jul 1;321(1):H242-H252. doi: 10.1152/ajpheart.00750.2020. Epub 2021 Jun 4.
Disturbed balance between matrix metalloproteinases (MMPs) and their respective tissue inhibitors (TIMPs) is a well-recognized pathophysiological component of pulmonary arterial hypertension (PAH). Both classes of proteinases have been associated with clinical outcomes as well as with specific pathological features of ventricular dysfunction and pulmonary arterial remodeling. The purpose of this study was to evaluate the circulating levels of MMPs and TIMPs in children with PAH undergoing the same-day cardiac magnetic resonance imaging (MRI) and right heart catheterization. Children with PAH ( = 21) underwent a same-day catheterization, comprehensive cardiac MRI evaluation, and blood sample collection for proteomic analysis. Correlative analysis was performed between protein levels and ) standard PAH indices from catheterization, ) cardiac MRI hemodynamics, and ) pulmonary arterial stiffness. MMP-8 was significantly associated with the right ventricular end-diastolic volume ( = 0.45, = 0.04). MMP-9 levels were significantly associated with stroke volume ( = -0.49, = 0.03) and pulmonary vascular resistance ( = 0.49, = 0.03). MMP-9 was further associated with main pulmonary arterial stiffness evaluated by relative area change ( = -0.79, < 0.01).TIMP-2 and TIMP-4 levels were further associated with the right pulmonary artery pulse wave velocity ( = 0.51, = 0.03) and backward compression wave ( = 0.52, = 0.02), respectively. MMPs and TIMPs warrant further clinically prognostic evaluation in conjunction with the conventional cardiac MRI hemodynamic indices. Metalloproteinases have been associated with clinical outcomes in pulmonary hypertension and with specific pathological features of ventricular dysfunction and pulmonary arterial remodeling. In this study, we demonstrated that plasma circulating levels of metalloproteinases and their inhibitors are associated with standard cardiac MRI hemodynamic indices and with the markers of proximal pulmonary arterial stiffness. Particularly, MMP-9 and TIMP-2 were associated with several different markers of pulmonary arterial stiffness. These findings suggest the interplay between the extracellular matrix (ECM) remodeling and overall hemodynamic status in children with PAH might be assessed using the peripheral circulating MMP and TIMP levels.
基质金属蛋白酶(MMPs)与其相应组织抑制剂(TIMPs)之间的平衡失调是肺动脉高压(PAH)的一种公认的病理生理组成部分。这两类蛋白酶都与临床结果以及心室功能障碍和肺动脉重塑的特定病理特征相关。本研究旨在评估同一天行心脏磁共振成像(MRI)和右心导管检查的 PAH 患儿的循环 MMP 和 TIMP 水平。PAH 患儿(n=21)行同一天导管检查、全面心脏 MRI 评估和血液样本采集进行蛋白质组学分析。对蛋白水平与)导管检查的标准 PAH 指标、)心脏 MRI 血液动力学和)肺动脉僵硬度进行相关分析。MMP-8 与右心室舒张末期容积显著相关(r=0.45,P=0.04)。MMP-9 水平与每搏量显著相关(r=-0.49,P=0.03)和肺血管阻力(r=0.49,P=0.03)。MMP-9 还与通过相对面积变化评估的主肺动脉僵硬度进一步相关(r=-0.79,P<0.01)。TIMP-2 和 TIMP-4 水平还与右肺动脉脉搏波速度(r=0.51,P=0.03)和后向压缩波(r=0.52,P=0.02)进一步相关。MMPs 和 TIMPs 与常规心脏 MRI 血液动力学指标结合,需要进一步进行临床预后评估。金属蛋白酶与肺动脉高压的临床结果以及心室功能障碍和肺动脉重塑的特定病理特征相关。在这项研究中,我们证明了血浆中循环 MMP 和其抑制剂的水平与标准心脏 MRI 血液动力学指标以及近端肺动脉僵硬度的标志物相关。特别是,MMP-9 和 TIMP-2 与肺动脉僵硬度的多个不同标志物相关。这些发现表明,在 PAH 患儿中,细胞外基质(ECM)重塑与整体血液动力学状态之间的相互作用可以通过外周循环 MMP 和 TIMP 水平来评估。